Glypican 3 antibody (C-Term)
Quick Overview for Glypican 3 antibody (C-Term) (ABIN307157)
Target
See all Glypican 3 (GPC3) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Cross-Reactivity
- Human
-
Characteristics
- GPC3, GPC-3, OCI5, OCI-5, GTR2-2, MXR7,Glypican-3 encodes a putative extracellular proteoglycan that is inferred to play an important role in growth control in embryonic mesodermal tissues in which it is selectively expressed. It appears to form a complex with insulin-like growth factor and hence modulate IGF2 action. Glypican-3 is the human homolog of OCI-5, a GPI-linked proteoglycan first isolated from rat intestine. Originally identified as the molecular basis for Simpson-Golabi-Behmel syndrome (SGBS) also called Simpson dysmorphia syndrome (SDYS).
-
Purification
- Total IgG
-
Immunogen
- C terminal recombinant protein (~70aa) which does not overlap with clone 1G12 epitope)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Antibody can be used for immunohistochemistry on paraffin-embedded tissues (10 μg/mL) and Western blotting (5-10 μg/mL). Optimal concentration should be evaluated by serial dilutions.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Provided as solution in phosphate buffered saline with 0.08 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles
-
-
- Glypican 3 (GPC3)
-
Alternative Name
- Glypican-3 (GPC3)
-
UniProt
- P51654
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-